Sometimes, the most significant breakthroughs come from refining what we already have, making established molecules more robust, more reliable, and more effective for study
Learn More News The Latest From Transcend Read More Press Release Transcend Therapeutics Announces Completion of Acquisition by Otsuka Pharmaceutical Read More Press Release Transcend Therapeutics Receives FDA National Priority Voucher for TSND-201 in PTSD Read More Press Release Otsuka Pharmaceutical to Acquire Transcend Therapeutics Read More Press Release IMPACT-1 Study Published in JAMA Psychiatry: Results of TSND-201 (Methylone) in Patients with Severe PTSD Learn More Our Mission Striving for a world without neuropsychiatric disease
Plenty of clients have stuck with their third-party manufacturing services for over many years now
Using the drug affinity response target stability technique, it was possible to observe that ASCT2 was protected from protein hydrolysis in a V-9302 concentration-dependent manner
Expect not just amazing customer service, but the warmth, care, and attention that you deserve, as we go the extra mile to make your journey with us as comfortable and rewarding as possible